Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Beth Han
Simultaneous Cannabis and Alcohol Use From Nationally Representative Data
Introduction Alcohol and cannabis are commonly used substances, with cannabis use increasing alongside expanding cannabis legalization.1 Although simultaneous alcohol-cannabis use has been associated with adverse outcomes,2 studies have compared simultaneous alcohol-cannabis use with alcohol-only use3,4 or with heterogeneous groups using alcohol only, cannabis only, and neither.5,6 To clarify alcohol-cannabis use patterns, identify risk factors, and strengthen clinical and public health...
Trends in the Prevalence and Severity of Alcohol and Cannabis Use Disorders Among US Adults
Supplement. Table 1.
Polysubstance use disorders among US adults
Abstract Polysubstance use disorders ( ≥ 2 substance use disorders (SUDs)) are associated with high morbidity and mortality. We analyzed data from 92,233 adult participants in the 2022–2023 US National Surveys on Drug Use and Health to estimate past-year prevalence of polysubstance use disorders and to examine their associations with age of substance use initiation. Multivariable logistic regression and Poisson regression were applied.
Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years
Figure 1. Dispensed Prescription Stimulants Among US Adults Aged 64 Years and Younger A, Number of unique individuals aged 18 to 64 years with dispensed stimulants by sex and age. The data source was the IQVIA Total Patient Tracker database. B, Number of prescription stimulants dispensed to adults aged 20 to 64 years by prescriber specialty.
Medically Recommended vs Nonmedical Cannabis Use Among US Adults
Medically Recommended vs Nonmedical Cannabis Use Among US Adults With increases in cannabis use for medical purposes and its perceived benefits,1,2 patients and clinicians need to be aware of its potential risks.
Prevalence of cannabis consumption methods among people with medically recommended and nonmedical cannabis use in the United States
REFERENCES 1, . Importance of a standard unit dose for cannabis research. Addiction. 2020; 115(7): 1219–1221. https://doi.org/10.1111/add.14984 2, , . In the weeds: a baseline view of cannabis use among legalizing states and their neighbors. Addiction. 2016; 111(6): 973–980. https://doi.org/10.1111/add.13282 3, , , , , . Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population. J Gen Intern Med. 2020; 35(7): 1979–1986.
Household Compositions and Substance Use among Young Adults in the U.S.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Prescription Opioid Use Disorder in US Adults Reporting Prescription Opioid Use
Abstract Objective: We examined prescription related opioid use disorder (POUD) prevalence, individual symptoms, severity, characteristics, and treatment by prescription opioid misuse status among adults with prescription opioid use. Methods: Cross-sectional study using nationally representative data from 47,291 adults aged ≥18 years who participated in the 2021 National Survey on Drug Use and Health. Past-year POUD used DSM-5 criteria.
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021
Key Points Question How many children in the US lost a parent to a drug overdose between 2011 and 2021, and does the rate vary by parent age, sex, or race and ethnicity? Findings In this cross-sectional study from 2011 to 2021, an estimated 321 566 community-dwelling children in the US lost a parent aged 18 to 64 years to drug overdose, and the rate of children who lost a parent to overdose increased during this period.
Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic
Key Points Questions How did pregnant and postpartum overdose decedents aged 10 to 44 years differ from obstetric decedents in the US? Findings In this cross-sectional study including 17 458 decedents, from 2018 to 2021, drug overdose mortality ratios rose (more than 3-fold in pregnant and postpartum individuals aged 35 to 44 years) across the pregnancy-postpartum continuum (the highest during late postpartum period since July 2020).
Patterns and Characteristics of Nicotine Dependence Among Adults With Cigarette Use in the US, 2006-2019
Key Points Question Does the national prevalence of nicotine dependence vary by year, age, psychiatric comorbidities (substance use disorder and/or depression), and sociodemographic characteristics?
United States trends in non‐prescribed use of Adderall and Ritalin: Population Assessment of Tobacco and Health (PATH) Study estimates from 2013 to 2022
INTRODUCTION Dispensing of prescription stimulants to adults, and especially females [1], has risen dramatically over the past decade in the United States (US). This increase has been one of the factors contributing to the current shortages of this medication class [2], which is seen as a first-line treatment for attention-deficit/hyperactivity disorder [3, 4].
Patterns and Characteristics of Nicotine Dependence Among Adults With Cigarette Use in the US, 2006-2019
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Racial and Ethnic Disparities in Drug Overdose Deaths in the US During the COVID-19 Pandemic
Recent reports highlighted racial and ethnic differences in US drug overdose deaths from 1999 to 2020.1,2 Overdose deaths increased 37.2% from February 2020 to August 2021 and were predominantly associated with synthetic opioids other than methadone (primarily fentanyl or analogs) and methamphetamine.3,4 Yet data are lacking regarding racial and ethnic disparities in overdose death rates within specific sex-age combinations before and during the COVID-19 pandemic (since March 2020).
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs | Psychiatry and Behavioral Health | JAMA Psychiatry | JAMA Network
On March 16, 2020, to facilitate access to methadone treatment from opioid treatment programs (OTPs) during the COVID-19 pandemic, the Substance Abuse and Mental Health Services Administration allowed states to request blanket exceptions to provide up to 28 and 14 days of take-home methadone for stable and less stable patients, respectively; this signaled a shift in practice because most patients historically receive methadone daily from OTPs.1 Prior research indicates most methadone-involved...
Trends in Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders, 2006-2019
Key Points Question Between 2006 and 2019, was there a change in prevalence of cigarette smoking among US adults with major depressive episode (MDE), substance use disorders (SUD), or both? Findings In this serial cross-sectional study that included 558 960 adult participants, there was a statistically significant decline in the prevalence of self-reported cigarette smoking from 2006 to 2019 among those with MDE (37.3% to 24.2%), SUD (46.5% to 35.8%), or both (50.7% to 37.0%).
Intentional Drug Overdose Deaths in the United States
During 1999–2019, age-adjusted rates of U.S. drug-involved overdose deaths more than tripled from 6.1 to 21.6 per 100,000 (1), and suicide rates (driven primarily by firearm suicide) increased 35.2% from 10.5 to 13.9 per 100,000 (2). However, no existing studies examined differences in trends in intentional overdose deaths by age, race/ethnicity, and sex, compared with firearm deaths by suicide (2–4). Furthermore, variations of intentional overdose deaths by month and day of the week are unknown.
Substance Use Disorders Are Deadly
Eating disorders (e.g., anorexia nervosa, bulimia nervosa) are associated with high premature mortality and are generally considered to be among the most lethal of all psychiatric disorders (1). Similarly, mortality from substance use disorders has been well documented during the current drug overdose crisis in the United States (2) and in numerous studies showing elevated death rates due to tobacco, alcohol, and other drugs (3–5).
Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US
Figure 1. US Adults Who Reported Using or Misusing Prescription Opioids in the Past 12 Months Data are from 42 739 respondents in the 2019 National Survey on Drug Use and Health (NSDUH). The 2015-2019 NSDUH did not collect information on the use of illicitly manufactured fentanyl; the fentanyl data shown are for prescription fentanyl.
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults
Key Points Question Are trends in methamphetamine use among populations with socioeconomic risk factors and comorbidities associated with increases in overdose mortality? Findings In this cross-sectional study of 195 711 respondents to a national survey from 2015 to 2019, methamphetamine use, frequent use, co-use with cocaine, and methamphetamine use disorder increased 43% to 105%.
Use of Medications for Alcohol Use Disorder in the US
Treatment rates for alcohol use disorder (AUD) are low1 (eg, 7.6% in 20192). The US Food and Drug Administration has approved 4 evidence-based medications for treating AUD (MAUD) since 1949.3 To improve use of MAUD, the American Psychiatric Association released guidelines for pharmacological treatments of patients with AUD in 2017.4 However, little is known about prevalence and associations of using MAUD among US adults with AUD.
Prevalence of Substance Use Disorders by Time Since First Substance Use Among Young People in the US
Earlier age at drug initiation has been shown to be associated with faster transition to substance use disorder (SUD).1 However, prevalence of specific SUDs as a function of time since first substance use among young people has not, to our knowledge, been investigated.
Associations of Suicidality Trends With Cannabis Use as a Function of Sex and Depression Status
Figure. Adjusted Past-Year Prevalence of Suicidal Ideation, Suicide Plan, and Suicide Attempt by Depression, Cannabis Use (CU) and CU Disorder (CUD), and Sex Data are stratified by sex, major depressive episode (MDE), CU, and CUD. Daily CU indicates 300 or more days per year.
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity
US age-adjusted rates of drug overdose deaths involving methamphetamine increased nearly 5-fold during 2012-2018.1 Although addiction outcomes can be improved with sex-specific and culturally tailored prevention and treatment interventions, the extent to which fatalities differ as functions of sex and race and ethnicity has not been analyzed, to our knowledge.
Reported Heroin Use, Use Disorder, and Injection Among Adults in the United States, 2002-2018
Heroin-related morbidity and mortality have increased over the past 17 years in the United States, including an increase in overdose deaths from 2089 in 2002 to 15 259 in 20181 and an increase of multiple outbreaks of HIV and hepatitis infections related to injection drug use.2-5 Yet research has not examined whether heroin injection is increasing.
Self-reported Medical and Nonmedical Cannabis Use Among Pregnant Women in the United States
Cannabis use increased among pregnant women in the United States from 2002 to 2014.1 However, changes in cannabis use and frequency by trimester over time and national prevalence of medical cannabis use during pregnancy are unknown. Data from the National Survey on Drug Use and Health (NSDUH) were examined to address these knowledge gaps.
Time since first cannabis use and 12‐month prevalence of cannabis use disorder among youth and emerging adults in the United States
Research Report Time since first cannabis use and 12‐month prevalence of cannabis use disorder among youth and emerging adults in the United States Beth Han Corresponding Author E-mail address: beth.han@samhsa.hhs.gov https://orcid.org/0000-0002-3861-1099 Substance Abuse and Mental Health Services Administration, Rockville, MD, USA Correspondence to: Beth Han, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane no. 15E85C, Rockville, MD 20857, USA.
Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults
Disclaimer: The findings and conclusions of this study are those of the authors and do not necessarily reflect the views of the Substance Abuse and Mental Health Services Administration, the National Institute on Drug Abuse of the National Institutes of Health, and the U.S. Department of Health and Human Services.
Cannabis Use and Cannabis Use Disorders Among Youth in the United States, 2002-2014
The article you requested is Objective: To examine trends in past-year cannabis use (CU) and cannabis use disorders (CUD) among youth in the United States, when related changes began, and factors associated with these changes. Methods: This study used data from 288,300 persons aged 12–17 years who participated in the 2002–2014 National Survey on Drug Use and Health.
Prevalence, Treatment, And Unmet Treatment Needs Of US Adults With Mental Health And Substance Use Disorders
We examined prevalence, treatment patterns, trends, and correlates of mental health and substance use treatments among adults with co-occurring disorders. Our data were from the 325,800 adults who participated in the National Survey on Drug Use and Health in the period 2008–14. Approximately 3.3 percent of the US adult population, or 7.7 million adults, had co-occurring disorders during the twelve months before the survey interview.
Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States
This was a nationally representative household population study of adults age 18 or older from the 2015 and 2016 National Surveys on Drug Use and Health (N=102,000). Measurements included prescription stimulant use, use without misuse, misuse without use disorders, and misuse with use disorders, as well as sociodemographic characteristics, health conditions, and mental health factors.
Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and HealthPrescription Opioid Use, Misuse, and Use Disorders in U.S. Adults
From Substance Abuse and Mental Health Services Administration, Rockville, Maryland; National Institute on Drug Abuse, Bethesda, Maryland; and Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Washington, DC. Note: Dr. Han had full access to all of the data in this study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Marijuana Use During Stages of Pregnancy in the United States
From National Institute on Drug Abuse, Bethesda, and Substance Abuse and Mental Health Services Administration, Rockville, Maryland. Note: Dr. Han had full access to all of the data in this study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults
Abstract OBJECTIVES: This study examined national trends in 12-month prevalence of major depressive episodes (MDEs) in adolescents and young adults overall and in different sociodemographic groups, as well as trends in depression treatment between 2005 and 2014. METHODS: Data were drawn from the National Surveys on Drug Use and Health for 2005 to 2014, which are annual cross-sectional surveys of the US general population.
National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults
National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults Ramin Mojtabai, Mark Olfson, Beth Han Pediatrics Nov 2016, e20161878; DOI: 10.1542/peds.2016-1878
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Beth
Contact Beth, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack